. Author manuscript; available in PMC: 2013 Sep 17.

Published in final edited form as: J Am Acad Dermatol. 2011 Jul;65(1):250–252. doi: 10.1016/j.jaad.2010.12.037

Table II.

Features of Cushing syndrome seen with systemic absorption of topical glucocorticoids^2,4,5

Nontreated skin:

Violaceous striae greater than 1 cm in width

Facial plethora

Skin atrophy

Increased lanugo hair, especially on face (women)

Glucocorticoid acne

Weight gain

Abnormal fat distribution (temporal fossae, supra-clavicular, dorsocervical areas, “moon” face)

Hypertension

Irregular or absent menses

Irritability, impaired memory or cognition

Abnormal glucose tolerance

In children, decreased growth velocity